An underground economy for unlicensed weight-loss medications is being driven by social media fitness personalities and sellers on communication apps, according to new investigations.
Experimental Drug Gaining Popularity Via Social Media
Retatrutide, which remains in research studies, is being promoted by social media influencers for its alleged fat-burning effects. Viewers are urged to contact these accounts directly for source information, while also receiving promotional offers.
Thriving Trade on Social Networks
Separately, a robust trade exists on Telegram, where communities with thousands of members share comparison photos, administration instructions and assertions of rapid British shipping. Vendors promote the drug there before redirecting customers to WhatsApp for purchases.
Learning About The Experimental Drug
Retatrutide is an experimental injectable created by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – GLP-1, GIP and glucagon. Preliminary studies indicate it could help individuals lose up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being promoted digitally as the next Ozempic.
Medical Professionals Voice Concerns
However, doctors and pharmacists have cautions that the distribution of what is still an unlicensed medication in the UK is worrisome and could lead to users administering substances of uncertain source.
Some experts stated the popularity for the experimental drug could be connected to the increasing cost of approved slimming products such as Mounjaro.
Legal Status and Implementation
Marketing the unapproved drug on TikTok or Telegram is prohibited in the UK, as it is an unlicensed drug that must not be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.
Several influencers attempt to circumvent the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and supply can still breach medicines, advertising, and customer regulations, potentially leading to fines, prosecution or prison.
Service Reaction and Content Removal
According to the social media company, the service has removed problematic content and prohibited related hashtags and search suggestions. The company said it was committed to keeping the service secure and allocating resources in strengthening enforcement strategies.
Digital Trading Operations
Investigations also found groups with up to 9,000 members marketing the experimental drug using the platform's integrated discovery tool, which operates like a online catalog. Entering “retatrutide” immediately brings up groups with thousands of members, populated with images of weight loss, positive testimonials and detailed guides for preparing or administering at home.
Within minutes of joining one group, a seller shared WhatsApp details, where the majority of transactions occur. The vendor provided an instruction manual and guaranteed shipping within 48 hours. When asked whether the product was genuine, one seller said: “You can’t be sure.” Another provided a image of a supposed testing documentation. None asked about body mass, medical conditions or previous experience.
Product Details and Pricing
Inside these groups, posts display black plastic parcels with postal service stickers, stating to include new batches. One message stated: “It took eight of us to load them this morning.”
Customers can select between dry substance containers, prepared at residence with purified liquid, or ready-to-use pens typically sold at 160 pounds for 20mg. When questioned how much time a pen should last, sellers give conflicting answers ranging from a few weeks to “depends on your body”.
Service Moderation and Security Actions
A spokesperson for the messaging service stated it actively monitored dangerous content on its platform including content that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Medical Expert Cautions
“People are administering materials they cannot confirm. Even if the science behind this drug is sound, these digital versions may not contain what they claim,” stated a pharmacy expert, the head of pharmacy at Chemist4U.
A medical professional of Asda Online Doctor connected the surge in interest to recent cost increases for authorized weight-loss drugs such as Mounjaro. “With prices rising, patients are turning to online platforms. But counterfeit injections are highly risky. You can’t be certain what’s contained or whether the environment they were produced in was clean,” she explained.
Her staff has previously encountered patients harmed by self-injection from unverified sources. “We recognize the frustration, but purchasing from messaging apps or WhatsApp is gambling with your well-being,” stated the doctor. “These substances could be contaminated or improperly measured.”
Producer Statement
A spokesperson from Eli Lilly said the substance was in third stage clinical trials and had not been evaluated or authorized by any government authority globally. “Consequently at this time no one can sell [it] for human use,” they explained, noting that any item “falsely representing itself as a company experimental substance not yet approved … may subject users to possibly significant medical dangers”.
